IMARC Group, a leading market research company, has released a report titled “Portable Oxygen Concentrators Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. According to the report, The global portable oxygen concentrators market size reached US$ 1.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.7 Billion by 2028, exhibiting a growth rate (CAGR) of 8.3% during 2023-2028.
Portable oxygen concentrators (POCs) are medical devices designed to deliver oxygen therapy to individuals with low oxygen levels in their blood. They are equipped with various delivery modes, such as pulse or on-demand and continuous flow, to ensure efficient oxygen delivery. They depend on either an electrical source or a portable battery to function and extract oxygen from the atmosphere to produce concentrated medical-grade gas. They are compact, lightweight, and easily portable. In addition, they can help achieve improved sleep, increased mental alertness, and enhanced stamina by providing a steady supply of oxygen. As a result, POCs are gaining immense traction among individuals with breathing disorders such as asthma and chronic obstructive pulmonary disease (COPD).
Request Free Sample Report: https://www.imarcgroup.com/portable-oxygen-concentrators-market/requestsample
Portable Oxygen Concentrators Market Trends and Drivers:
The market is primarily driven by the rising incidences of respiratory disorders, including pulmonary fibrosis, lung cancer, and pneumonia, among individuals across the globe. In addition, the growing geriatric population susceptible to these ailments, and increasing awareness regarding advanced care methods is contributing to the market growth. Moreover, technological advancements in POCs, such as improved battery life and miniaturized membrane technology, represents another major growth-inducing factor. Besides this, the recent onset of the coronavirus disease (COVID-19) pandemic has also accelerated the demand for POCs. Along with this, the surging needs for high-quality oxygen due to the increasing environmental pollution caused by carbon dioxide (CO2) emissions are propelling the market growth. Furthermore, the escalating product demand among travelers and mountaineers who require oxygen in places with inadequate oxygen levels is creating a positive market outlook.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Technology:
- Continuous Flow
- Pulse Flow
Breakup by Application:
- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Respiratory Distress Syndrome
- Sleep Apnea
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Others
Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- The Middle East and Africa
Competitive Landscape with Key Player:
- Caire Inc. (NGK Spark Plug Co. Ltd)
- Chart Industries Inc.
- Drive Devilbiss Healthcare Limited (Drive International LLC)
- Inogen Inc.
- Invacare Corporation
- Koninklijke Philips N.V.
- Nidek Medical India Pvt Ltd
- O2 Concepts LLC
- Precision Medical Inc. (BioHorizons Inc.)
- Resmed Inc.
- Teijin Limited.
Ask Analyst for Free Sample Report: https://www.imarcgroup.com/request?type=report&id=2699&flag=F
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: sales@imarcgroup.com
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal
